e-learning
resources
Munich 2014
Sunday, 07.09.2014
The assessment of comorbidities
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The metabolic syndrome in patients with chronic obstructive pulmonary disease
A. A. Daouud, A. Khoury, L. Shakerdi (Aleppo, Syrian Arab Republic)
Source:
International Congress 2014 – The assessment of comorbidities
Session:
The assessment of comorbidities
Session type:
Thematic Poster Session
Number:
979
Disease area:
Airway diseases, Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. A. Daouud, A. Khoury, L. Shakerdi (Aleppo, Syrian Arab Republic). The metabolic syndrome in patients with chronic obstructive pulmonary disease. Eur Respir J 2014; 44: Suppl. 58, 979
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Abdulla Khouri - 17.09.2014 17:50
A wondefull study regarding the civil war in SYRIA.
Many thanks for The ERS scientific committe
Mats Arne (Karlstad, Sweden) - 09.09.2014 21:25
Brilliant poster!
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on acute decompensated pulmonary hypertension
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Chronic obstructive pulmonary disease (COPD) and alterations of hemogram
Source: International Congress 2014 – Systemic biomarkers for airway diseases
Year: 2014
Frequency of depression in patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014
Clinical presentation of chronic obstructive pulmonary disease (COPD): Study on-sint
Source: International Congress 2014 – Clinical assessment of airway diseases
Year: 2014
Do co-morbidities in patients with chronic obstructive pulmonary disease affect outcomes?
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014
Assessment of patients preferences regarding characteristics associated with treatment of chronic obstructive pulmonary disease
Source: International Congress 2014 – Systemic biomarkers for airway diseases
Year: 2014
Clinical factors linked with coronary artery disease in chronic obstructive pulmonary disease (COPD)
Source: International Congress 2014 – Non inflammatory monitoring of airway diseases
Year: 2014
Severity of airway obstruction in overweight/obese patients with chronic obstructive pulmonary disease(COPD)
Source: International Congress 2014 – Monitoring airway diseases with lung function tests
Year: 2014
Study of inflammatory markers and BODE index in patients with chronic obstructive pulmonary disease
Source: International Congress 2016 – Systemic biomarkers
Year: 2016
Adipokines and ghrelin in chronic obstructive pulmonary disease
Source: Annual Congress 2013 –COPD treatment and others
Year: 2013
Associations between muscle wasting and BODE index in chronic obstructive pulmonary disease
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014
Relation between pulmonary arterial remodeling and parenchymal disease in severe COPD and interstitial lung disease patients
Source: International Congress 2014 – Pulmonary hypertension in lung disease
Year: 2014
Pulmonary hypertension correction in patients with chronic obstructive pulmonary disease and essential hypertension
Source: International Congress 2014 – Pulmonary hypertension in lung disease
Year: 2014
Diabetes mellitus and obstructive pulmonary disease. Is there an association?
Source: International Congress 2014 – Direct and indirect monitoring of comorbidities
Year: 2014
Effect of pulmonary-specific vasodilator therapy in patients with chronic obstructive pulmonary disease and pulmonary hypertension. A retrospective analysis
Source: International Congress 2014 – Pulmonary hypertension in lung disease
Year: 2014
Metabolic syndrome in chronic obstructive pulmonary disease
Source: International Congress 2018 – Nutrition and metabolic syndrome in COPD
Year: 2018
Systemic vascular function in chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment
Year: 2013
Effect of statins on endothelial dysfunction in patients with chronic obstructive pulmonary disease and metabolic syndrome
Source: International Congress 2014 – Mechanisms of COPD and inhalation injury
Year: 2014
Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Investigating COPD in longitudinal studies
Year: 2013
Subclinical atherosclerosis, airflow obstruction and emphysema: the MESA Lung Study
Source: Eur Respir J 2012; 39: 846-854
Year: 2012
Biomarkers in the management of COPD
Source: Eur Respir Rev 2009; 18: 96-104
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept